Evidence map›Paper›PMID 28884524›Full record

ArticleJournal of the International AIDS Society2017

HIV transmission and retention in care among HIV-exposed children enrolled in Malawi's prevention of mother-to-child transmission programme.

Andreas D Haas, Joep J van Oosterhout, Lyson Tenthani, Andreas Jahn, Marcel Zwahlen, Malango T Msukwa, Mary-Ann Davies, Kali Tal, Nozgechi Phiri, Adrian Spoerri and 3 more

Open access · goldAbstract read
In one paragraph

Article in Journal of the International AIDS Society, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
3.2field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 37 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Observational
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 6 institutions in 3 countries.

Andreas D HaasInstitute of Social and Preventive Medicine (ISPM), University of Bern, Bern, Switzerland.
Joep J van OosterhoutDignitas International, Zomba, Malawi.
Lyson TenthaniInstitute of Social and Preventive Medicine (ISPM), University of Bern, Bern, Switzerland.
Andreas JahnInternational Training & Education Center for Health Malawi, Lilongwe, Malawi.
Marcel ZwahlenInstitute of Social and Preventive Medicine (ISPM), University of Bern, Bern, Switzerland.
Malango T MsukwaInstitute of Social and Preventive Medicine (ISPM), University of Bern, Bern, Switzerland.
Mary-Ann DaviesCentre of Infectious Disease Epidemiology and Research (CIDER), University of Cape Town, Cape Town, South Africa.
Kali TalInstitute of Social and Preventive Medicine (ISPM), University of Bern, Bern, Switzerland.
Nozgechi PhiriInstitute of Social and Preventive Medicine (ISPM), University of Bern, Bern, Switzerland.
Adrian SpoerriInstitute of Social and Preventive Medicine (ISPM), University of Bern, Bern, Switzerland.
Frank ChimbwandiraMinistry of Health, Lilongwe, Malawi.
Matthias EggerInstitute of Social and Preventive Medicine (ISPM), University of Bern, Bern, Switzerland.
Olivia KeiserInstitute of Social and Preventive Medicine (ISPM), University of Bern, Bern, Switzerland.
University of Bern · CHInstitute of Social and Preventive Medicine · CHMinistry of Health · MWWellcome Centre for Infectious Diseases Research in Africa · ZABaobab Health Trust · MWDignitas International · MW

Funding

Observational Antiretroviral Studies In Southern Africa (OASIS) CollaborationU01AI069924 · NIAID · UNIVERSITAT BERN · PI Cleophas Chimbetete, Mary-Ann Davies · 2006 to 2026
$55.9M
Bill and Melinda Gates Foundation OPP1090200National Institute of Allergy and Infectious Diseases 5U01-AI069924NIAID NIH HHS U01 AI069924PEPFARSchweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung 3233B-150934Stavros Niarchos Foundation 163878United States Agency for International Development AID-OAA-A-11-00012
6 · The paper itself

Abstract

introductionIn Malawi, HIV-infected pregnant and breastfeeding women are offered lifelong antiretroviral therapy (ART) regardless of CD4 count or clinical stage (Option B+). Their HIV-exposed children are enrolled in the national prevention of mother-to-child transmission (PMTCT) programme, but many are lost to follow-up. We estimated the cumulative incidence of vertical HIV transmission, taking loss to follow-up into account.

methodsWe abstracted data from HIV-exposed children enrolled into care between September 2011 and June 2014 from patient records at 21 health facilities in central and southern Malawi. We used competing risk models to estimate the probability of loss to follow-up, death, ART initiation and discharge, and used pooled logistic regression and inverse probability of censoring weighting to estimate the vertical HIV transmission risk.

resultsA total of 11,285 children were included; 9285 (82%) were born to women who initiated ART during pregnancy. At age 30 months, an estimated 57.9% (95% CI 56.6-59.2) of children were lost to follow-up, 0.8% (0.6-1.0) had died, 2.6% (2.3-3.0) initiated ART, 36.5% (35.2-37.9) were discharged HIV-negative and 2.2% (1.5-2.8) continued follow-up. We estimated that 5.3% (95% CI 4.7-5.9) of the children who enrolled were HIV-infected by the age of 30 months, but only about half of these children (2.6%; 95% CI 2.3-2.9) were diagnosed.

conclusionsConfirmed mother-to-child transmission rates were low, but due to poor retention only about half of HIV-infected children were diagnosed. Tracing of children lost to follow-up and HIV testing in outpatient clinics should be scaled up to ensure that all HIV-positive children have access to early ART.

Indexed as

Contact TracingAdultAnti-HIV AgentsBreast FeedingChild, PreschoolFemaleHIV InfectionsHumansInfantInfant, NewbornInfectious Disease Transmission, VerticalLogistic ModelsLost to Follow-UpMalawiMaleMothersAnti-HIV AgentsOption B+Prevention of mother-to-child transmission (PMTCT)retention

Identifiers

PMID28884524
PMCPMC5640313
OpenAlexW2751705353

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.